1031 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Bronchogenic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
3 Not yet recruiting Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
Condition: Bronchial Cancer
Intervention: Device: With and without SDB
4 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
5 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
6 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
7 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
8 Not yet recruiting Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Osimertinib
9 Recruiting Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Radiation: IMRT + SIB + Chemotherapy
10 Not yet recruiting A Trial of CV301 in Combination With Nivolumab Versus Nivolumab in Subjects With Previously Treated Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer (NSCLC)
Interventions: Biological: CV301;   Biological: nivolumab
11 Recruiting The Effect of Combined General/Regional Anesthesia on Cancer Recurrence in Patients Having Lung Cancer Resections
Condition: Non-small Cell Lung Cancer
Interventions: Drug: General anesthesia;   Drug: Combined general/epidural anesthesia
12 Recruiting CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor
Conditions: Hepatocellular Carcinoma;   Non-small Cell Lung Cancer;   Pancreatic Carcinoma;   Triple-Negative Invasive Breast Carcinoma;   Malignant Glioma of Brain;   Colorectal Carcinoma;   Gastric Carcinoma
Intervention: Biological: anti-MUC1 CAR-pNK cells
13 Recruiting FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: FLT3 Ligand Therapy (CDX-301);   Radiation: Stereotactic Body Radiotherapy (SBRT)
14 Recruiting Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Conditions: Non-small Cell Lung Cancer;   Esophageal Cancer;   Gastric Cancer;   Pancreatic Cancer;   Hepatocellular Cancer;   Colorectal Cancer
Intervention: Other: Blood draws, urine and tissue asservation, bone marrow aspiration
15 Recruiting A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
Condition: Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer
Interventions: Drug: Alectinib;   Drug: Crizotinib
16 Recruiting Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors
Conditions: Renal Cell Carcinoma;   Colorectal Adenocarcinoma;   Non-squamous Non-small Cell Lung Cancer;   Platinum-refractory Ovarian Carcinoma;   Cervical Carcinoma
Interventions: Drug: Nintedanib;   Drug: Bevacizumab
17 Not yet recruiting Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Pembrolizumab (MK-3475) in Chinese Participants With Non-Small-Cell Lung Cancer (MK-3475-032/KEYNOTE-032)
Condition: Non-Small-Cell Lung Cancer
Intervention: Biological: Pembrolizumab
18 Not yet recruiting Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now
Condition: Non-Small-Cell Lung Cancer
Intervention:
19 Not yet recruiting Patient Function/Fitness and Psychosocial Health in Improving Health-Related Quality of Life in Patients With Stage I-IV Non-Small Cell Lung Cancer
Conditions: Smoking;   Lung Neoplasms
Interventions: Other: Integrated Fitness Assessment;   Procedure: Psychosocial Assessment and Care;   Procedure: Quality-of-Life Assessment
20 Not yet recruiting A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation
Condition: Non Small Cell Lung
Intervention: Drug: pyrotinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years